about
Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International MeetingDengue virus infection in AfricaTackling dengue fever: Current status and challengesFever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public healthAn in-depth analysis of original antigenic sin in dengue virus infectionIntroducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendationsRole of microparticles in dengue virus infection and its impact on medical intervention strategiesHeritable strategies for controlling insect vectors of diseaseSynergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesDevelopment of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysViral Vaccines and CTL ResponseAllosteric Inhibition of the NS2B-NS3 Protease from Dengue VirusThe kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assemblyField cage studies and progressive evaluation of genetically-engineered mosquitoesAntiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infectionsDengue fever: a Wikipedia clinical reviewSpatial variation of insecticide resistance in the dengue vector Aedes aegypti presents unique vector control challengesDengue research opportunities in the AmericasAssessing the potential of a candidate dengue vaccine with mathematical modelingComparison of Two Detailed Models of Aedes aegypti Population Dynamics.Determinants of felt demand for dengue vaccines in the North Caribbean region of ColombiaIssues related to recent dengue vaccine development.Extensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses.The neglected arboviral infections in mainland China.Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production.A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compoundA new approach to monitoring dengue activityEndemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmissionInduction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in miceDengue vaccines: state of the art.Consequences of non-intervention for infectious disease in African great apes.Dengue.Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving.Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccineMale mating history and body size influence female fecundity and longevity of the dengue vector Aedes aegypti.Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam
P2860
Q21562244-1532D5BA-BC7F-4E0C-8387-B5D06ACA1F96Q22305632-2B21EFE9-67A2-48A4-AFCE-727E499FFCBBQ24288867-F3A87215-7915-4EA0-8380-AC1A9D12EB29Q24289308-8D8387D5-E847-4AB8-94CD-139C3DF6DF40Q24606493-3449DFB7-7E12-4EDB-901A-F1A142B00EFFQ26823330-0554D607-BEB1-40F1-B5B9-600F9114CA83Q26860307-7CA4ADD7-7BED-4D2A-A091-56D31A5697B4Q26866094-747ED766-0C97-48B2-A75D-6B1E222D9E27Q27305534-97D00F0B-1A21-493B-9609-428A77791793Q27334248-538DAEF6-813A-4A8E-8C73-BB44D7AA8CABQ27491049-79454EE7-C9C5-42BD-BB81-616215AF4C7FQ27491330-098ED2DA-ADC2-4470-8849-90B61A31C84AQ27680467-F6B6439C-1D1E-4BA6-99D1-33A4590F730AQ28476602-94E73ADC-7678-4337-9D49-3FC57CE45E13Q28485161-168F73FF-0A54-4C5C-B561-B6AEBB02A423Q28584386-A64B2DC9-6BE0-47E0-B42B-D8C52DBA0935Q28651505-94573DCD-6135-4C37-AD63-AF9F6EB79BC1Q28656081-6EEB5AD2-C52E-48BD-B20E-3EFCA6E6FB41Q28656204-3BEF6474-D470-43ED-BDA3-011288C33E56Q28730914-C3679232-700B-4B86-88ED-E3220860B6F0Q30145660-4D789D75-86D3-434D-B040-F6AFF17347F8Q30250964-017E3A1F-1043-49DF-AC81-DAD4A7120838Q30395396-6E53C1BD-6539-40D8-A2B4-48F89E592EF3Q30423742-AECE88D1-B973-4DE4-9098-B7ACADC5379DQ33570581-F7663716-B8FB-46D1-AFEE-B0F4B12C2E1CQ33774668-4BABC507-65F2-414A-8D3C-6EC8205C501FQ33802834-A040B0B3-F4A2-42F2-B390-326C04DC6D4DQ33852451-8C2E115E-1EBC-42AC-A4BB-7B7812737E46Q33918841-CA5D4014-5227-42CC-838B-E9D9F4F4FA35Q33925216-CC769823-C398-4FE8-BC9A-8F7FFECE7F72Q33926902-838092B6-5BA0-4162-81CA-7113783C4FF1Q34059579-61DC3B1E-A144-4DE5-8328-AEC7321EB095Q34066921-0D06EE50-AC3B-4901-872D-16874A1A6623Q34109652-F99EBE68-1785-48FA-9F55-9B04B7B7C342Q34117137-34974016-6480-43B3-A52D-054B6D682B81Q34125057-425F5214-3FAC-440F-BF16-190CDD0C79C7Q34166919-21FA54D7-7FD6-4BF1-96DC-082A896326C8Q34262245-B029147A-F576-4B73-AEDC-65E2C88BDFF2Q34278958-89891C0E-F05C-4160-874A-2A02027AFD94Q34422217-6B32D19C-953C-42D0-995A-F4E512C9F5D0
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Progress towards a dengue vaccine.
@ast
Progress towards a dengue vaccine.
@en
type
label
Progress towards a dengue vaccine.
@ast
Progress towards a dengue vaccine.
@en
prefLabel
Progress towards a dengue vaccine.
@ast
Progress towards a dengue vaccine.
@en
P1476
Progress towards a dengue vaccine.
@en
P2093
Daniel P Webster
Sarah Rowland-Jones
P304
P356
10.1016/S1473-3099(09)70254-3
P5008
P577
2009-11-01T00:00:00Z